5 New Diabetes Technologies for Patient Empowerment

November 18, 2017

Five slides, 5 snapshots of products that help reduce fingerstick anxiety, enhance medication adherence, and prevent plantar ulcers.

The challenges of diabetes self management cut across all domains of daily life and patient success in meeting all of them every day will be variable, even in the face of all good intentions.The technology to assist and support patients with diabetes with almost any aspect of disease managment is already available and is being refined continuously.Â This short slide show offers a quick look at 5 new products that help reduce pain, enhance medication accuracy and adherence, and prevent plantar ulcers.Â References: 1. Frykberg RG, Gordon IL, Reyzelman AM, et al. Feasibility and efficacy of a smart mat to predict development of diabetic plantar ulcers. Diabetes Care 2017 Apr; dc162294.

GlucosePATH ** SmartMat ** QuiO Smartinjector ** Genteel Lancing Device ** Dexcom CGM

GlucosePATH ** Cost/availability: Currently in its first clinical trial, not yet available as a commercial product ** (Note: Does not include decision-making guidance for cholesterol and high blood pressure medications) ** MORE INFORMATION

SmartMat ** Cost/availability: Currently piloted in more than 500 homes ** MORE INFORMATION

QuiO Smartinjector Platform ** Cost/availability: Final prototype device is currently in production; software is pending finalization; release of Si One is expected in 2017 * MORE INFORMATION

Genteel Lancing Device ** Cost/availability: $129 ** MORE INFORMATION

Dexcom G6 Continuous Glucose Monitor ** Cost/availability: Dexcom is targeting G6 for a third quarter FDA submission and 2018 launch, with a second generation expected in 2020 ** MORE INFORMATION